Qiagen (QGEN) Tops Q3 EPS by 11c; Guides Higher

Go back to Qiagen (QGEN) Tops Q3 EPS by 11c; Guides Higher

QIAGEN Reports Strong Results for Third Quarter and First Nine Months Of 2021

November 3, 2021 4:08 PM EDT

Q3 2021: Net sales rise 11% (+10% constant exchange rates, CER) to $535 million and adjusted diluted EPS unchanged at $0.58 ($0.58 CER) from Q3 2020, both well above outlook Non-COVID product group sales grow 17% CER to $376 million building on excellent H1 2021 trends, COVID-19 product group sales decline 4% CER to $159 million 9M 2021: Net sales grow 28% (+25% CER) to $1.67 billion, non-COVID sales rise 27% CER to $1.15 billion; adjusted diluted EPS of $1.91 ($1.88 CER) 9M 2021: Operating cash flow up 134% to $441 million, free cash flow up 198% to $302 million Full-year 2021: Outlook upgraded to reflect... More